1. Home
  2. NKTR vs USAS Comparison

NKTR vs USAS Comparison

Compare NKTR & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • USAS
  • Stock Information
  • Founded
  • NKTR 1990
  • USAS 1998
  • Country
  • NKTR United States
  • USAS Canada
  • Employees
  • NKTR N/A
  • USAS N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • USAS Metal Mining
  • Sector
  • NKTR Health Care
  • USAS Basic Materials
  • Exchange
  • NKTR Nasdaq
  • USAS Nasdaq
  • Market Cap
  • NKTR 247.9M
  • USAS 285.0M
  • IPO Year
  • NKTR 1994
  • USAS N/A
  • Fundamental
  • Price
  • NKTR $0.90
  • USAS $0.50
  • Analyst Decision
  • NKTR Strong Buy
  • USAS Strong Buy
  • Analyst Count
  • NKTR 5
  • USAS 1
  • Target Price
  • NKTR $4.50
  • USAS $0.80
  • AVG Volume (30 Days)
  • NKTR 1.5M
  • USAS 614.8K
  • Earning Date
  • NKTR 03-03-2025
  • USAS 11-07-2024
  • Dividend Yield
  • NKTR N/A
  • USAS N/A
  • EPS Growth
  • NKTR N/A
  • USAS N/A
  • EPS
  • NKTR N/A
  • USAS N/A
  • Revenue
  • NKTR $93,137,000.00
  • USAS $97,123,000.00
  • Revenue This Year
  • NKTR $12.85
  • USAS $21.84
  • Revenue Next Year
  • NKTR N/A
  • USAS $46.00
  • P/E Ratio
  • NKTR N/A
  • USAS N/A
  • Revenue Growth
  • NKTR 5.53
  • USAS 14.33
  • 52 Week Low
  • NKTR $0.50
  • USAS $0.20
  • 52 Week High
  • NKTR $1.93
  • USAS $0.54
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 40.16
  • USAS 71.63
  • Support Level
  • NKTR $0.87
  • USAS $0.38
  • Resistance Level
  • NKTR $0.94
  • USAS $0.41
  • Average True Range (ATR)
  • NKTR 0.09
  • USAS 0.03
  • MACD
  • NKTR -0.01
  • USAS 0.01
  • Stochastic Oscillator
  • NKTR 15.63
  • USAS 91.16

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.

Share on Social Networks: